Unadjusted HR (95% CI) (n=1631) | Adjusted HR (95% CI)* (n=1497) | |
---|---|---|
Institutionalisation | ||
Non-frail participants not on statins† | 1.00 | 1.00 |
Non-frail participants on statins | 0.93 (0.60 to 1.44) | 1.43 (0.81 to 2.51) |
Frail participants not on statins | 4.58 (2.82 to 7.44) | 2.07 (1.11 to 3.86) |
Frail participants on statins | 5.47 (3.11 to 9.61) | 4.34 (2.02 to 9.33) |
Death | ||
Non-frail participants not on statins | 1.00 | 1.00 |
Non-frail participants on statins | 1.05 (0.83 to 1.35) | 0.90 (0.66 to 1.23) |
Frail participants not on statins | 3.40 (2.49 to 4.65) | 1.53 (1.03 to 2.28) |
Frail participants on statins | 3.01 (1.97 to 4.61) | 1.24 (0.71 to 2.17) |
*Adjusted for age, education, marital status, alcohol use, smoking, body mass index, self-reported comorbidities, self-reported cardiovascular diseases, impaired vision, depression, cognitive impairment, functional status, self-rated health, polypharmacy, total cholesterol, high-density lipoprotein cholesterol and triglyceride concentrations.
†Non-users, the reference group.